Advertisement

The Nutshell

Daily News Roundup

Most Recent

$Billions of fraud in HHS programs

By | June 16, 2008

The Department of Health and Human Services Office of Inspector General (OIG) will recover more than $2 billion through audits and investigations of fraud, waste and abuse in HHS programs, the office linkurl:announced;http://www.oig.hhs.gov/publications/docs/press/2008/semiannual_press_spring2008.pdf last Thursday (Jun 12). "OIG's accomplishments reflect a robust oversight agenda implemented through audits, evaluations, and compliance and enforcement activities," said Inspector General linkurl:

3 Comments

Reprogramming ups mortality?

By | June 16, 2008

Chimeric mice generated from cells reprogrammed for pluripotency (induced pluripotent stem cells, or iPS cells) show significant health problems, pointing to further challenges that must be overcome before such cells can be used in the clinic, noted iPS researcher Shinya Yamanaka said on Saturday (June 14). Speaking at the linkurl:meeting;http://www.the-scientist.com/blog/display/54746/ of the linkurl:International Society for Stem Cell Research;http://www.the-scientist.com/blog/display/54749/

4 Comments

A fine time for equines

By | June 13, 2008

The American Museum of Natural History's new exhibit explores the human - horse relationship When I was seven years old I decided I'd rather be a horse than a human. In an attempt to dissuade me from this point of view, my parents had me start riding lessons when I was nine. It didn't work. I am still convinced the horse is a superior creature. So I was the natural choice from __The Scientist__'s editorial office to review __The Horse__, a new exhibition at the American Museum of Natural Hist

0 Comments

Embryonic stem cells still gold standard

By | June 13, 2008

The technical challenges of using retroviruses to reprogram cells to a pluripotent state could be worked out within the year, researchers said today in a press conference at the annual meeting of the International Society for Stem Cell Research in Philadelphia. However, they stressed, human embryonic stem cells are still, and will continue to be, the gold standard for research on pluripotency and differentiation. The speakers, including linkurl:George Daley;http://www.childrenshospital.org/cfap

0 Comments

Compounds target cancer stem cells

By | June 12, 2008

New compounds that target leukemia stem cells are moving into the clinic this summer. But researchers have yet to pin down exactly how some of these compounds do their job. Today at the International Society for Stem Cell Research's (ISSCR) annual meeting, linkurl:Craig Jordan;http://www.urmc.rochester.edu/GEBS/faculty/Craig_Jordan.htm from the University of Rochester presented his group's recent work on a compound TDZD-8, which was originally developed to inhibit GSK-3, and potentially treat A

1 Comment

Invitrogen and Applied Biosystems merge

By | June 12, 2008

Biotech company linkurl:Invitrogen;http://www.the-scientist.com/article/display/13263/ announced today (Jun 12) that it will acquire linkurl:Applied Biosystems;http://www.the-scientist.com/article/display/15680/ in a deal valued at $6.7 billion. "This transaction combines the industry's premier consumables provider with the industry's premier systems provider to create a world-class biotechnology tools company," said linkurl:Gregory Lucier,;http://www.biotech360.com/biotechArticleDisplay.jsp?bi

1 Comment

Stem cell guidelines on the way

By | June 12, 2008

You can now have your say about regulations on bringing stem cell therapies to the clinic. A special task force set up to create guidelines for bringing stem cell therapies from bench to bedside will be accepting public commentary on the guidelines, continuing until this fall, the group announced today at the annual meeting of the International Society for Stem Cell Research (ISSCR) here in Philadelphia. The task force's primary goals are to create guidelines that will help basic researchers

1 Comment

GSK slashes workforce

By | June 11, 2008

In another move to encourage innovation while trimming its research and development budget, pharmaceutical company GlaxoSmithKline has announced that it will cut two percent, or 350 jobs, from its global R&D staff, according to linkurl:__The Wall Street Journal__.;http://online.wsj.com/article/SB121318410957563897.html?mod=hps_us_at_glance_health "These changes are part of GSK's longer-term strategy to ensure that we invest in key areas of future growth and evolve our business to compete effect

1 Comment

Senate tweaks bioterror regs

By | June 11, 2008

The US Senate today (June 11) plans to introduce a biosafety bill that takes small steps towards resolving some controversial aspects of the system regulating research with agents that could be used for bioterrorism. The regulations, called the Select Agent Program, have been controversial since they were established in 2002. Researchers have said that the rules linkurl:created red tape;http://www.the-scientist.com/article/display/14717/ that stymied research, hindered international collaborati

1 Comment

Trees have internal thermostat

By | June 11, 2008

Trees from the linkurl:Caribbean;http://www.the-scientist.com/article/display/53628/ to linkurl:Canada;http://www.the-scientist.com/article/display/15054/ maintain a constant leaf temperature regardless of the ambient air temperature, according to a new study by researchers at the University of Pennsylvania. The findings could dramatically alter interpretations of data used to approximate past climate from the composition of tree rings, the researchers say. Scientists who measure cellulose com

5 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Shimadzu Scientific
Shimadzu Scientific
Advertisement
The Scientist